Caris Life Sciences, Inc. (CAI)
26.03
-7.19
(-21.64%)
USD |
NASDAQ |
Nov 05, 16:00
26.20
+0.17
(+0.65%)
After-Hours: 20:00
Caris Life Sciences Cash from Investing (Quarterly) : -17.47M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -17.47M |
| June 30, 2026 | -122.19M |
| March 31, 2026 | -10.34M |
| December 31, 2025 | -5.09M |
| September 30, 2025 | -7.095M |
| June 30, 2025 | -1.386M |
| Date | Value |
|---|---|
| March 31, 2025 | -2.689M |
| December 31, 2024 | -2.29M |
| September 30, 2024 | -1.828M |
| June 30, 2024 | -2.588M |
| March 31, 2024 | 59.64M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Natera, Inc. | -63.43M |
| Myriad Genetics, Inc. | -2.10M |
| BioRestorative Therapies, Inc. | 0.9684M |
| CareDx, Inc. | -147.88M |
| Exagen, Inc. | -0.543M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -22.25M |
| Cash from Financing (Quarterly) | 14.23M |
| Free Cash Flow | 21.20M |
| Free Cash Flow Per Share (Quarterly) | -0.1346 |
| Free Cash Flow to Equity (Quarterly) | -50.33M |
| Free Cash Flow to Firm (Quarterly) | -31.36M |
| Free Cash Flow Yield | 0.28% |